BACKGROUND: Micro-inflammation and changes in gut microbiota may play a role in the pathogenesis of diverticular disease (DD). OBJECTIVE: The objective of this article is to evaluate the expression of nitric oxide (NO)-related mediators and S100B in colonic mucosa of patients with DD in an ex vivo model of bacterial infection. METHODS: Intestinal biopsies obtained from patients with diverticulosis, symptomatic uncomplicated diverticular disease (SUDD) and SUDD with previous acute diverticulitis (SUDD+AD) were stimulated with the probiotic L. casei DG® (LCDG) and/or the pathogen enteroinvasive Escherichia coli (EIEC). S100B, NO release and iNOS expression were then evaluated. RESULTS: Basal iNOS expression was significantly increased in SUDD and SUDD+AD patients. Basal NO expression was significantly increased in SUDD+AD. No differences in S100B release were found. In all groups, iNOS expression was significantly increased by EIEC and reduced by LCDG. In all groups, except for SUDD+AD, EIEC significantly increased NO release, whereas no increase was observed when LCDG was added to biopsies. EIEC did not induce significant changes in S100B release. CONCLUSIONS: Colonic mucosa of patients with DD is characterized by a different reactivity toward pathogenic stimuli. LCDG plays a role in counteracting the pro-inflammatory effects exerted by EIEC, suggesting a beneficial role of this probiotic in DD.
BACKGROUND:Micro-inflammation and changes in gut microbiota may play a role in the pathogenesis of diverticular disease (DD). OBJECTIVE: The objective of this article is to evaluate the expression of nitric oxide (NO)-related mediators and S100B in colonic mucosa of patients with DD in an ex vivo model of bacterial infection. METHODS: Intestinal biopsies obtained from patients with diverticulosis, symptomatic uncomplicated diverticular disease (SUDD) and SUDD with previous acute diverticulitis (SUDD+AD) were stimulated with the probiotic L. casei DG® (LCDG) and/or the pathogen enteroinvasive Escherichia coli (EIEC). S100B, NO release and iNOS expression were then evaluated. RESULTS: Basal iNOS expression was significantly increased in SUDD and SUDD+AD patients. Basal NO expression was significantly increased in SUDD+AD. No differences in S100B release were found. In all groups, iNOS expression was significantly increased by EIEC and reduced by LCDG. In all groups, except for SUDD+AD, EIEC significantly increased NO release, whereas no increase was observed when LCDG was added to biopsies. EIEC did not induce significant changes in S100B release. CONCLUSIONS:Colonic mucosa of patients with DD is characterized by a different reactivity toward pathogenic stimuli. LCDG plays a role in counteracting the pro-inflammatory effects exerted by EIEC, suggesting a beneficial role of this probiotic in DD.
Authors: G Bassotti; E Battaglia; G Bellone; L Dughera; S Fisogni; C Zambelli; A Morelli; P Mioli; G Emanuelli; V Villanacci Journal: J Clin Pathol Date: 2005-09 Impact factor: 3.411
Authors: Daniel Martin Commane; Ramesh Pulendran Arasaradnam; Sarah Mills; John Cummings Mathers; Mike Bradburn Journal: World J Gastroenterol Date: 2009-05-28 Impact factor: 5.742
Authors: C Cirillo; G Sarnelli; G Esposito; M Grosso; R Petruzzelli; P Izzo; G Calì; F P D'Armiento; A Rocco; G Nardone; T Iuvone; L Steardo; R Cuomo Journal: Neurogastroenterol Motil Date: 2009-06-24 Impact factor: 3.598
Authors: Maria Raffaella Barbaro; Cesare Cremon; Daniele Fuschi; Giovanni Marasco; Marta Palombo; Vincenzo Stanghellini; Giovanni Barbara Journal: Int J Mol Sci Date: 2022-06-15 Impact factor: 6.208
Authors: Ralf Jäger; Javier Zaragoza; Martin Purpura; Stefania Iametti; Mauro Marengo; Grant M Tinsley; Anthony J Anzalone; Jonathan M Oliver; Walter Fiore; Andrea Biffi; Stacie Urbina; Lem Taylor Journal: Probiotics Antimicrob Proteins Date: 2020-12 Impact factor: 4.609